Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

Cell therapy is emerging as a cutting-edge precision treatment in ophthalmology and is gaining immense popularity worldwide among people affected by degenerative eye diseases. Traditional therapies ...

The development of ocular signs of neurofibromatosis type 1 (NF1) is only significant in patients 7 years of age and younger.

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...

Do blue light glasses actually help with sleep or eye strain? We explore the science behind blue light exposure, circadian disruption, and whether these lenses are worth the hype.

Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye ...

AI models trained on optical coherence tomography scans to detect eye diseases are showing promise in diagnosing heart ...

Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...